Global Biologics and Biosimilars Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Biosimilars are biomedical products that are almost identical to the original products made by different companies. Biosimilars are officially recognized versions of the original 'innovator' products that can be produced when the original product patent expires. Reference to innovative products is an integral part of the approval.
Based on the Biologics and Biosimilars market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Biologics and Biosimilars market covered in Chapter 5:
United Laboratories
Pfizer
Novo Nordisk
Amgen
Novartis
Sanofi-Aventis
Roche
Innovent
Changchun High Tech
Biotech
Johnson & Johnson
Dong Bao
Eli Lilly
CP Guojian
Merck
3sbio
Gelgen
AbbVie
Ganlee
In Chapter 6, on the basis of types, the Biologics and Biosimilars market from 2015 to 2025 is primarily split into:
Growth Factors
Hormone
Antibody
In Chapter 7, on the basis of applications, the Biologics and Biosimilars market from 2015 to 2025 covers:
Cardiovascular
Diabetes
Tumor
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Based on the Biologics and Biosimilars market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Biologics and Biosimilars market covered in Chapter 5:
United Laboratories
Pfizer
Novo Nordisk
Amgen
Novartis
Sanofi-Aventis
Roche
Innovent
Changchun High Tech
Biotech
Johnson & Johnson
Dong Bao
Eli Lilly
CP Guojian
Merck
3sbio
Gelgen
AbbVie
Ganlee
In Chapter 6, on the basis of types, the Biologics and Biosimilars market from 2015 to 2025 is primarily split into:
Growth Factors
Hormone
Antibody
In Chapter 7, on the basis of applications, the Biologics and Biosimilars market from 2015 to 2025 covers:
Cardiovascular
Diabetes
Tumor
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Biologics and Biosimilars Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 United Laboratories
5.1.1 United Laboratories Company Profile
5.1.2 United Laboratories Business Overview
5.1.3 United Laboratories Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 United Laboratories Biologics and Biosimilars Products Introduction
5.2 Pfizer
5.2.1 Pfizer Company Profile
5.2.2 Pfizer Business Overview
5.2.3 Pfizer Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Pfizer Biologics and Biosimilars Products Introduction
5.3 Novo Nordisk
5.3.1 Novo Nordisk Company Profile
5.3.2 Novo Nordisk Business Overview
5.3.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Novo Nordisk Biologics and Biosimilars Products Introduction
5.4 Amgen
5.4.1 Amgen Company Profile
5.4.2 Amgen Business Overview
5.4.3 Amgen Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Amgen Biologics and Biosimilars Products Introduction
5.5 Novartis
5.5.1 Novartis Company Profile
5.5.2 Novartis Business Overview
5.5.3 Novartis Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Novartis Biologics and Biosimilars Products Introduction
5.6 Sanofi-Aventis
5.6.1 Sanofi-Aventis Company Profile
5.6.2 Sanofi-Aventis Business Overview
5.6.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Sanofi-Aventis Biologics and Biosimilars Products Introduction
5.7 Roche
5.7.1 Roche Company Profile
5.7.2 Roche Business Overview
5.7.3 Roche Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Roche Biologics and Biosimilars Products Introduction
5.8 Innovent
5.8.1 Innovent Company Profile
5.8.2 Innovent Business Overview
5.8.3 Innovent Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Innovent Biologics and Biosimilars Products Introduction
5.9 Changchun High Tech
5.9.1 Changchun High Tech Company Profile
5.9.2 Changchun High Tech Business Overview
5.9.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Changchun High Tech Biologics and Biosimilars Products Introduction
5.10 Biotech
5.10.1 Biotech Company Profile
5.10.2 Biotech Business Overview
5.10.3 Biotech Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Biotech Biologics and Biosimilars Products Introduction
5.11 Johnson & Johnson
5.11.1 Johnson & Johnson Company Profile
5.11.2 Johnson & Johnson Business Overview
5.11.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Johnson & Johnson Biologics and Biosimilars Products Introduction
5.12 Dong Bao
5.12.1 Dong Bao Company Profile
5.12.2 Dong Bao Business Overview
5.12.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Dong Bao Biologics and Biosimilars Products Introduction
5.13 Eli Lilly
5.13.1 Eli Lilly Company Profile
5.13.2 Eli Lilly Business Overview
5.13.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Eli Lilly Biologics and Biosimilars Products Introduction
5.14 CP Guojian
5.14.1 CP Guojian Company Profile
5.14.2 CP Guojian Business Overview
5.14.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 CP Guojian Biologics and Biosimilars Products Introduction
5.15 Merck
5.15.1 Merck Company Profile
5.15.2 Merck Business Overview
5.15.3 Merck Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Merck Biologics and Biosimilars Products Introduction
5.16 3sbio
5.16.1 3sbio Company Profile
5.16.2 3sbio Business Overview
5.16.3 3sbio Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 3sbio Biologics and Biosimilars Products Introduction
5.17 Gelgen
5.17.1 Gelgen Company Profile
5.17.2 Gelgen Business Overview
5.17.3 Gelgen Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Gelgen Biologics and Biosimilars Products Introduction
5.18 AbbVie
5.18.1 AbbVie Company Profile
5.18.2 AbbVie Business Overview
5.18.3 AbbVie Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 AbbVie Biologics and Biosimilars Products Introduction
5.19 Ganlee
5.19.1 Ganlee Company Profile
5.19.2 Ganlee Business Overview
5.19.3 Ganlee Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Ganlee Biologics and Biosimilars Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biologics and Biosimilars Sales and Market Share by Types (2015-2020)
6.1.2 Global Biologics and Biosimilars Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biologics and Biosimilars Price by Types (2015-2020)
6.2 Global Biologics and Biosimilars Market Forecast by Types (2020-2025)
6.2.1 Global Biologics and Biosimilars Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biologics and Biosimilars Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biologics and Biosimilars Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biologics and Biosimilars Sales, Price and Growth Rate of Growth Factors
6.3.2 Global Biologics and Biosimilars Sales, Price and Growth Rate of Hormone
6.3.3 Global Biologics and Biosimilars Sales, Price and Growth Rate of Antibody
6.4 Global Biologics and Biosimilars Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Growth Factors Market Revenue and Sales Forecast (2020-2025)
6.4.2 Hormone Market Revenue and Sales Forecast (2020-2025)
6.4.3 Antibody Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biologics and Biosimilars Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biologics and Biosimilars Revenue and Market Share by Applications (2015-2020)
7.2 Global Biologics and Biosimilars Market Forecast by Applications (2020-2025)
7.2.1 Global Biologics and Biosimilars Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biologics and Biosimilars Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biologics and Biosimilars Revenue, Sales and Growth Rate of Cardiovascular (2015-2020)
7.3.2 Global Biologics and Biosimilars Revenue, Sales and Growth Rate of Diabetes (2015-2020)
7.3.3 Global Biologics and Biosimilars Revenue, Sales and Growth Rate of Tumor (2015-2020)
7.4 Global Biologics and Biosimilars Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Cardiovascular Market Revenue and Sales Forecast (2020-2025)
7.4.2 Diabetes Market Revenue and Sales Forecast (2020-2025)
7.4.3 Tumor Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Biologics and Biosimilars Sales by Regions (2015-2020)
8.2 Global Biologics and Biosimilars Market Revenue by Regions (2015-2020)
8.3 Global Biologics and Biosimilars Market Forecast by Regions (2020-2025)
9 NORTH AMERICA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
9.3 North America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
9.4 North America Biologics and Biosimilars Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biologics and Biosimilars Market Analysis by Country
9.6.1 U.S. Biologics and Biosimilars Sales and Growth Rate
9.6.2 Canada Biologics and Biosimilars Sales and Growth Rate
9.6.3 Mexico Biologics and Biosimilars Sales and Growth Rate
10 EUROPE BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
10.3 Europe Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biologics and Biosimilars Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biologics and Biosimilars Market Analysis by Country
10.6.1 Germany Biologics and Biosimilars Sales and Growth Rate
10.6.2 United Kingdom Biologics and Biosimilars Sales and Growth Rate
10.6.3 France Biologics and Biosimilars Sales and Growth Rate
10.6.4 Italy Biologics and Biosimilars Sales and Growth Rate
10.6.5 Spain Biologics and Biosimilars Sales and Growth Rate
10.6.6 Russia Biologics and Biosimilars Sales and Growth Rate
11 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biologics and Biosimilars Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biologics and Biosimilars Market Analysis by Country
11.6.1 China Biologics and Biosimilars Sales and Growth Rate
11.6.2 Japan Biologics and Biosimilars Sales and Growth Rate
11.6.3 South Korea Biologics and Biosimilars Sales and Growth Rate
11.6.4 Australia Biologics and Biosimilars Sales and Growth Rate
11.6.5 India Biologics and Biosimilars Sales and Growth Rate
12 SOUTH AMERICA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
12.3 South America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
12.4 South America Biologics and Biosimilars Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biologics and Biosimilars Market Analysis by Country
12.6.1 Brazil Biologics and Biosimilars Sales and Growth Rate
12.6.2 Argentina Biologics and Biosimilars Sales and Growth Rate
12.6.3 Columbia Biologics and Biosimilars Sales and Growth Rate
13 MIDDLE EAST AND AFRICA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biologics and Biosimilars Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biologics and Biosimilars Market Analysis by Country
13.6.1 UAE Biologics and Biosimilars Sales and Growth Rate
13.6.2 Egypt Biologics and Biosimilars Sales and Growth Rate
13.6.3 South Africa Biologics and Biosimilars Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Biologics and Biosimilars Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 United Laboratories
5.1.1 United Laboratories Company Profile
5.1.2 United Laboratories Business Overview
5.1.3 United Laboratories Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 United Laboratories Biologics and Biosimilars Products Introduction
5.2 Pfizer
5.2.1 Pfizer Company Profile
5.2.2 Pfizer Business Overview
5.2.3 Pfizer Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Pfizer Biologics and Biosimilars Products Introduction
5.3 Novo Nordisk
5.3.1 Novo Nordisk Company Profile
5.3.2 Novo Nordisk Business Overview
5.3.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Novo Nordisk Biologics and Biosimilars Products Introduction
5.4 Amgen
5.4.1 Amgen Company Profile
5.4.2 Amgen Business Overview
5.4.3 Amgen Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Amgen Biologics and Biosimilars Products Introduction
5.5 Novartis
5.5.1 Novartis Company Profile
5.5.2 Novartis Business Overview
5.5.3 Novartis Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Novartis Biologics and Biosimilars Products Introduction
5.6 Sanofi-Aventis
5.6.1 Sanofi-Aventis Company Profile
5.6.2 Sanofi-Aventis Business Overview
5.6.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Sanofi-Aventis Biologics and Biosimilars Products Introduction
5.7 Roche
5.7.1 Roche Company Profile
5.7.2 Roche Business Overview
5.7.3 Roche Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Roche Biologics and Biosimilars Products Introduction
5.8 Innovent
5.8.1 Innovent Company Profile
5.8.2 Innovent Business Overview
5.8.3 Innovent Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Innovent Biologics and Biosimilars Products Introduction
5.9 Changchun High Tech
5.9.1 Changchun High Tech Company Profile
5.9.2 Changchun High Tech Business Overview
5.9.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Changchun High Tech Biologics and Biosimilars Products Introduction
5.10 Biotech
5.10.1 Biotech Company Profile
5.10.2 Biotech Business Overview
5.10.3 Biotech Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Biotech Biologics and Biosimilars Products Introduction
5.11 Johnson & Johnson
5.11.1 Johnson & Johnson Company Profile
5.11.2 Johnson & Johnson Business Overview
5.11.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Johnson & Johnson Biologics and Biosimilars Products Introduction
5.12 Dong Bao
5.12.1 Dong Bao Company Profile
5.12.2 Dong Bao Business Overview
5.12.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Dong Bao Biologics and Biosimilars Products Introduction
5.13 Eli Lilly
5.13.1 Eli Lilly Company Profile
5.13.2 Eli Lilly Business Overview
5.13.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Eli Lilly Biologics and Biosimilars Products Introduction
5.14 CP Guojian
5.14.1 CP Guojian Company Profile
5.14.2 CP Guojian Business Overview
5.14.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 CP Guojian Biologics and Biosimilars Products Introduction
5.15 Merck
5.15.1 Merck Company Profile
5.15.2 Merck Business Overview
5.15.3 Merck Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Merck Biologics and Biosimilars Products Introduction
5.16 3sbio
5.16.1 3sbio Company Profile
5.16.2 3sbio Business Overview
5.16.3 3sbio Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 3sbio Biologics and Biosimilars Products Introduction
5.17 Gelgen
5.17.1 Gelgen Company Profile
5.17.2 Gelgen Business Overview
5.17.3 Gelgen Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Gelgen Biologics and Biosimilars Products Introduction
5.18 AbbVie
5.18.1 AbbVie Company Profile
5.18.2 AbbVie Business Overview
5.18.3 AbbVie Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 AbbVie Biologics and Biosimilars Products Introduction
5.19 Ganlee
5.19.1 Ganlee Company Profile
5.19.2 Ganlee Business Overview
5.19.3 Ganlee Biologics and Biosimilars Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Ganlee Biologics and Biosimilars Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biologics and Biosimilars Sales and Market Share by Types (2015-2020)
6.1.2 Global Biologics and Biosimilars Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biologics and Biosimilars Price by Types (2015-2020)
6.2 Global Biologics and Biosimilars Market Forecast by Types (2020-2025)
6.2.1 Global Biologics and Biosimilars Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biologics and Biosimilars Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biologics and Biosimilars Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biologics and Biosimilars Sales, Price and Growth Rate of Growth Factors
6.3.2 Global Biologics and Biosimilars Sales, Price and Growth Rate of Hormone
6.3.3 Global Biologics and Biosimilars Sales, Price and Growth Rate of Antibody
6.4 Global Biologics and Biosimilars Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Growth Factors Market Revenue and Sales Forecast (2020-2025)
6.4.2 Hormone Market Revenue and Sales Forecast (2020-2025)
6.4.3 Antibody Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biologics and Biosimilars Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biologics and Biosimilars Revenue and Market Share by Applications (2015-2020)
7.2 Global Biologics and Biosimilars Market Forecast by Applications (2020-2025)
7.2.1 Global Biologics and Biosimilars Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biologics and Biosimilars Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biologics and Biosimilars Revenue, Sales and Growth Rate of Cardiovascular (2015-2020)
7.3.2 Global Biologics and Biosimilars Revenue, Sales and Growth Rate of Diabetes (2015-2020)
7.3.3 Global Biologics and Biosimilars Revenue, Sales and Growth Rate of Tumor (2015-2020)
7.4 Global Biologics and Biosimilars Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Cardiovascular Market Revenue and Sales Forecast (2020-2025)
7.4.2 Diabetes Market Revenue and Sales Forecast (2020-2025)
7.4.3 Tumor Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Biologics and Biosimilars Sales by Regions (2015-2020)
8.2 Global Biologics and Biosimilars Market Revenue by Regions (2015-2020)
8.3 Global Biologics and Biosimilars Market Forecast by Regions (2020-2025)
9 NORTH AMERICA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
9.3 North America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
9.4 North America Biologics and Biosimilars Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biologics and Biosimilars Market Analysis by Country
9.6.1 U.S. Biologics and Biosimilars Sales and Growth Rate
9.6.2 Canada Biologics and Biosimilars Sales and Growth Rate
9.6.3 Mexico Biologics and Biosimilars Sales and Growth Rate
10 EUROPE BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
10.3 Europe Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biologics and Biosimilars Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biologics and Biosimilars Market Analysis by Country
10.6.1 Germany Biologics and Biosimilars Sales and Growth Rate
10.6.2 United Kingdom Biologics and Biosimilars Sales and Growth Rate
10.6.3 France Biologics and Biosimilars Sales and Growth Rate
10.6.4 Italy Biologics and Biosimilars Sales and Growth Rate
10.6.5 Spain Biologics and Biosimilars Sales and Growth Rate
10.6.6 Russia Biologics and Biosimilars Sales and Growth Rate
11 ASIA-PACIFIC BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biologics and Biosimilars Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biologics and Biosimilars Market Analysis by Country
11.6.1 China Biologics and Biosimilars Sales and Growth Rate
11.6.2 Japan Biologics and Biosimilars Sales and Growth Rate
11.6.3 South Korea Biologics and Biosimilars Sales and Growth Rate
11.6.4 Australia Biologics and Biosimilars Sales and Growth Rate
11.6.5 India Biologics and Biosimilars Sales and Growth Rate
12 SOUTH AMERICA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
12.3 South America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
12.4 South America Biologics and Biosimilars Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biologics and Biosimilars Market Analysis by Country
12.6.1 Brazil Biologics and Biosimilars Sales and Growth Rate
12.6.2 Argentina Biologics and Biosimilars Sales and Growth Rate
12.6.3 Columbia Biologics and Biosimilars Sales and Growth Rate
13 MIDDLE EAST AND AFRICA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biologics and Biosimilars Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biologics and Biosimilars Market Analysis by Country
13.6.1 UAE Biologics and Biosimilars Sales and Growth Rate
13.6.2 Egypt Biologics and Biosimilars Sales and Growth Rate
13.6.3 South Africa Biologics and Biosimilars Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Biologics and Biosimilars Market Size and Growth Rate 2015-2025
Table Biologics and Biosimilars Key Market Segments
Figure Global Biologics and Biosimilars Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biologics and Biosimilars Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biologics and Biosimilars
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table United Laboratories Company Profile
Table United Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure United Laboratories Production and Growth Rate
Figure United Laboratories Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table Sanofi-Aventis Company Profile
Table Sanofi-Aventis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi-Aventis Production and Growth Rate
Figure Sanofi-Aventis Market Revenue ($) Market Share 2015-2020
Table Roche Company Profile
Table Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Production and Growth Rate
Figure Roche Market Revenue ($) Market Share 2015-2020
Table Innovent Company Profile
Table Innovent Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Innovent Production and Growth Rate
Figure Innovent Market Revenue ($) Market Share 2015-2020
Table Changchun High Tech Company Profile
Table Changchun High Tech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Changchun High Tech Production and Growth Rate
Figure Changchun High Tech Market Revenue ($) Market Share 2015-2020
Table Biotech Company Profile
Table Biotech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biotech Production and Growth Rate
Figure Biotech Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Dong Bao Company Profile
Table Dong Bao Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dong Bao Production and Growth Rate
Figure Dong Bao Market Revenue ($) Market Share 2015-2020
Table Eli Lilly Company Profile
Table Eli Lilly Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Market Revenue ($) Market Share 2015-2020
Table CP Guojian Company Profile
Table CP Guojian Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CP Guojian Production and Growth Rate
Figure CP Guojian Market Revenue ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck Production and Growth Rate
Figure Merck Market Revenue ($) Market Share 2015-2020
Table 3sbio Company Profile
Table 3sbio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure 3sbio Production and Growth Rate
Figure 3sbio Market Revenue ($) Market Share 2015-2020
Table Gelgen Company Profile
Table Gelgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gelgen Production and Growth Rate
Figure Gelgen Market Revenue ($) Market Share 2015-2020
Table AbbVie Company Profile
Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie Production and Growth Rate
Figure AbbVie Market Revenue ($) Market Share 2015-2020
Table Ganlee Company Profile
Table Ganlee Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ganlee Production and Growth Rate
Figure Ganlee Market Revenue ($) Market Share 2015-2020
Table Global Biologics and Biosimilars Sales by Types (2015-2020)
Table Global Biologics and Biosimilars Sales Share by Types (2015-2020)
Table Global Biologics and Biosimilars Revenue ($) by Types (2015-2020)
Table Global Biologics and Biosimilars Revenue Share by Types (2015-2020)
Table Global Biologics and Biosimilars Price ($) by Types (2015-2020)
Table Global Biologics and Biosimilars Market Forecast Sales by Types (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Sales Share by Types (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue Share by Types (2020-2025)
Figure Global Growth Factors Sales and Growth Rate (2015-2020)
Figure Global Growth Factors Price (2015-2020)
Figure Global Hormone Sales and Growth Rate (2015-2020)
Figure Global Hormone Price (2015-2020)
Figure Global Antibody Sales and Growth Rate (2015-2020)
Figure Global Antibody Price (2015-2020)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Growth Factors (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Growth Factors (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Hormone (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Hormone (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Antibody (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Antibody (2020-2025)
Table Global Biologics and Biosimilars Sales by Applications (2015-2020)
Table Global Biologics and Biosimilars Sales Share by Applications (2015-2020)
Table Global Biologics and Biosimilars Revenue ($) by Applications (2015-2020)
Table Global Biologics and Biosimilars Revenue Share by Applications (2015-2020)
Table Global Biologics and Biosimilars Market Forecast Sales by Applications (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Sales Share by Applications (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Cardiovascular Sales and Growth Rate (2015-2020)
Figure Global Cardiovascular Price (2015-2020)
Figure Global Diabetes Sales and Growth Rate (2015-2020)
Figure Global Diabetes Price (2015-2020)
Figure Global Tumor Sales and Growth Rate (2015-2020)
Figure Global Tumor Price (2015-2020)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Cardiovascular (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Cardiovascular (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Diabetes (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Diabetes (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Tumor (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Tumor (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Sales by Regions (2015-2020)
Table Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Figure Global Biologics and Biosimilars Sales Market Share by Regions in 2019
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Revenue by Regions (2015-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Regions (2015-2020)
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2019
Table Global Biologics and Biosimilars Market Forecast Sales by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Sales Share by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure North America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure North America Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure North America Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Canada Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Mexico Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Europe Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure Europe Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure France Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Italy Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Spain Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Russia Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Japan Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South Korea Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Australia Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure India Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure South America Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure South America Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Argentina Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Columbia Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure UAE Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Egypt Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South Africa Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global Biologics and Biosimilars Market Size and Growth Rate 2015-2025
Table Biologics and Biosimilars Key Market Segments
Figure Global Biologics and Biosimilars Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biologics and Biosimilars Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biologics and Biosimilars
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table United Laboratories Company Profile
Table United Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure United Laboratories Production and Growth Rate
Figure United Laboratories Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table Sanofi-Aventis Company Profile
Table Sanofi-Aventis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi-Aventis Production and Growth Rate
Figure Sanofi-Aventis Market Revenue ($) Market Share 2015-2020
Table Roche Company Profile
Table Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Roche Production and Growth Rate
Figure Roche Market Revenue ($) Market Share 2015-2020
Table Innovent Company Profile
Table Innovent Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Innovent Production and Growth Rate
Figure Innovent Market Revenue ($) Market Share 2015-2020
Table Changchun High Tech Company Profile
Table Changchun High Tech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Changchun High Tech Production and Growth Rate
Figure Changchun High Tech Market Revenue ($) Market Share 2015-2020
Table Biotech Company Profile
Table Biotech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biotech Production and Growth Rate
Figure Biotech Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Dong Bao Company Profile
Table Dong Bao Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Dong Bao Production and Growth Rate
Figure Dong Bao Market Revenue ($) Market Share 2015-2020
Table Eli Lilly Company Profile
Table Eli Lilly Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Market Revenue ($) Market Share 2015-2020
Table CP Guojian Company Profile
Table CP Guojian Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CP Guojian Production and Growth Rate
Figure CP Guojian Market Revenue ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck Production and Growth Rate
Figure Merck Market Revenue ($) Market Share 2015-2020
Table 3sbio Company Profile
Table 3sbio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure 3sbio Production and Growth Rate
Figure 3sbio Market Revenue ($) Market Share 2015-2020
Table Gelgen Company Profile
Table Gelgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gelgen Production and Growth Rate
Figure Gelgen Market Revenue ($) Market Share 2015-2020
Table AbbVie Company Profile
Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie Production and Growth Rate
Figure AbbVie Market Revenue ($) Market Share 2015-2020
Table Ganlee Company Profile
Table Ganlee Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ganlee Production and Growth Rate
Figure Ganlee Market Revenue ($) Market Share 2015-2020
Table Global Biologics and Biosimilars Sales by Types (2015-2020)
Table Global Biologics and Biosimilars Sales Share by Types (2015-2020)
Table Global Biologics and Biosimilars Revenue ($) by Types (2015-2020)
Table Global Biologics and Biosimilars Revenue Share by Types (2015-2020)
Table Global Biologics and Biosimilars Price ($) by Types (2015-2020)
Table Global Biologics and Biosimilars Market Forecast Sales by Types (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Sales Share by Types (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue Share by Types (2020-2025)
Figure Global Growth Factors Sales and Growth Rate (2015-2020)
Figure Global Growth Factors Price (2015-2020)
Figure Global Hormone Sales and Growth Rate (2015-2020)
Figure Global Hormone Price (2015-2020)
Figure Global Antibody Sales and Growth Rate (2015-2020)
Figure Global Antibody Price (2015-2020)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Growth Factors (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Growth Factors (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Hormone (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Hormone (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Antibody (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Antibody (2020-2025)
Table Global Biologics and Biosimilars Sales by Applications (2015-2020)
Table Global Biologics and Biosimilars Sales Share by Applications (2015-2020)
Table Global Biologics and Biosimilars Revenue ($) by Applications (2015-2020)
Table Global Biologics and Biosimilars Revenue Share by Applications (2015-2020)
Table Global Biologics and Biosimilars Market Forecast Sales by Applications (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Sales Share by Applications (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Cardiovascular Sales and Growth Rate (2015-2020)
Figure Global Cardiovascular Price (2015-2020)
Figure Global Diabetes Sales and Growth Rate (2015-2020)
Figure Global Diabetes Price (2015-2020)
Figure Global Tumor Sales and Growth Rate (2015-2020)
Figure Global Tumor Price (2015-2020)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Cardiovascular (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Cardiovascular (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Diabetes (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Diabetes (2020-2025)
Figure Global Biologics and Biosimilars Market Revenue ($) and Growth Rate Forecast of Tumor (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast of Tumor (2020-2025)
Figure Global Biologics and Biosimilars Sales and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Sales by Regions (2015-2020)
Table Global Biologics and Biosimilars Sales Market Share by Regions (2015-2020)
Figure Global Biologics and Biosimilars Sales Market Share by Regions in 2019
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Revenue by Regions (2015-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Regions (2015-2020)
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2019
Table Global Biologics and Biosimilars Market Forecast Sales by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Sales Share by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure North America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure North America Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure North America Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Canada Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Mexico Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Europe Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Europe Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure Europe Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure France Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Italy Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Spain Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Russia Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Japan Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South Korea Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Australia Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure India Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South America Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South America Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure South America Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure South America Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Argentina Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Columbia Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics and Biosimilars Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biologics and Biosimilars Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biologics and Biosimilars Market Forecast Revenue ($) (2020-2025)
Figure UAE Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure Egypt Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
Figure South Africa Biologics and Biosimilars Market Sales and Growth Rate (2015-2020)
